BMEYE B.V., based in the Netherlands, was established in April 2005, as a management buyout of a business unit of TNO. BMEYE's unique non-invasive blood pressure and cardiac output technology has been matured and validated over the last 20 years; from experimental product launches for the space industry and research area BMEYE miniaturized the technology and made it user friendly for clinical application. BMEYE's mission is to become the premier provider and to set the standard of non-invasive, beat-to-beat and user friendly cardiovascular monitoring systems to improve patient care and reduce healthcare costs. BMEYE launched Nexfin. In April 2007 in Europe, the US introduction followed in the January 2008. Nexfin is a unique product fulfilling an unmet need for clinical non-invasive, beat-to-beat hemodynamic monitoring with applications in cardiology and critical care.

Web: www.bmeye.com